SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,395,670 | -6.4% | 28,012 | -11.6% | 0.00% | -33.3% |
| Q2 2023 | $3,628,848 | -8.0% | 31,687 | +10.7% | 0.00% | 0.0% |
| Q1 2023 | $3,944,620 | +18.5% | 28,619 | +11.4% | 0.00% | 0.0% |
| Q4 2022 | $3,329,747 | +10.2% | 25,696 | -6.0% | 0.00% | 0.0% |
| Q3 2022 | $3,022,000 | +40.3% | 27,338 | -4.9% | 0.00% | +50.0% |
| Q2 2022 | $2,154,000 | -8.0% | 28,741 | -4.1% | 0.00% | 0.0% |
| Q1 2022 | $2,341,000 | -9.9% | 29,972 | +3.9% | 0.00% | 0.0% |
| Q4 2021 | $2,598,000 | -11.2% | 28,854 | -8.8% | 0.00% | -33.3% |
| Q3 2021 | $2,926,000 | +44.6% | 31,642 | +21.5% | 0.00% | +50.0% |
| Q2 2021 | $2,024,000 | +24.2% | 26,037 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $1,630,000 | -52.8% | 21,870 | +7.9% | 0.00% | -50.0% |
| Q4 2020 | $3,457,000 | +20.6% | 20,275 | -0.7% | 0.00% | 0.0% |
| Q3 2020 | $2,867,000 | -9.9% | 20,418 | +2.8% | 0.00% | -33.3% |
| Q2 2020 | $3,183,000 | +75.6% | 19,853 | +7.1% | 0.01% | +50.0% |
| Q1 2020 | $1,813,000 | +24.7% | 18,537 | +64.6% | 0.00% | +33.3% |
| Q4 2019 | $1,454,000 | +23.1% | 11,265 | -28.1% | 0.00% | +50.0% |
| Q3 2019 | $1,181,000 | -53.2% | 15,674 | -5.6% | 0.00% | -60.0% |
| Q2 2019 | $2,523,000 | +60.6% | 16,607 | +26.0% | 0.01% | +25.0% |
| Q1 2019 | $1,571,000 | +16.7% | 13,179 | +6.8% | 0.00% | 0.0% |
| Q4 2018 | $1,346,000 | -43.5% | 12,337 | -16.4% | 0.00% | -33.3% |
| Q3 2018 | $2,382,000 | +32.8% | 14,750 | +8.7% | 0.01% | +20.0% |
| Q2 2018 | $1,794,000 | +92.5% | 13,574 | +7.9% | 0.01% | +66.7% |
| Q1 2018 | $932,000 | +44.9% | 12,579 | +8.8% | 0.00% | +50.0% |
| Q4 2017 | $643,000 | +6.8% | 11,559 | -27.8% | 0.00% | 0.0% |
| Q4 2015 | $602,000 | +79.2% | 16,016 | +99.4% | 0.00% | 0.0% |
| Q3 2015 | $336,000 | +24.9% | 8,033 | -10.6% | 0.00% | +100.0% |
| Q2 2015 | $269,000 | +32.5% | 8,983 | -3.3% | 0.00% | 0.0% |
| Q3 2014 | $203,000 | -13.2% | 9,288 | +18.1% | 0.00% | 0.0% |
| Q2 2014 | $234,000 | +6.4% | 7,865 | -14.2% | 0.00% | 0.0% |
| Q1 2014 | $220,000 | -26.9% | 9,165 | +37.5% | 0.00% | -50.0% |
| Q3 2013 | $301,000 | +49.0% | 6,665 | +25.8% | 0.00% | +100.0% |
| Q2 2013 | $202,000 | – | 5,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |